Faeth Therapeutics, Inc.
(FTH - NASDAQ)
40,05 USD
📋 Profilo Aziendale

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company'…

|